A preliminary study on the effects of atropine sulphate on bradycardia and heart blocks during romifidine sedation in the horse.
Abstract: Romifidine (STH 2130-Cl or Sedivet) is an alpha 2-agonistic imino-imidazol sedative for intravenous use in horses recently developed by Boehringer Ingelheim, Vetmedica GmbH. An exploratory study was done in nine warm-blood horses, randomly divided into three groups, which received different dosages of romifidine (0.04, 0.08 and 0.12 mg/kg of body weight (BWT) intravenously (i.v.)) with at least one week's interval between tests. Romifidine induced a marked bradycardia accompanied by second degree atrioventricular (AV) block and some sinus blocks at all tested dosages. A placebo (NaCl 0.9% i.v.) given 5 min before and after romifidine did not affect the cardiac disturbances induced by romifidine. A low dose of atropine sulphate (0.005 mg/kg of BWT i.v.) given 5 min before romifidine counteracted the bradycardia and caused a normal to increased heart rhythm at all romifidine dosages. A higher dose of atropine sulphate (0.01 mg/kg of BWT i.v.) administered 5 min before sedation induced a tachycardia (average 70 beats/min) at all romifidine dosages and completely prevented the bradycardia and the heart blocks. The positive chronotrope effects of atropine sulphate were attenuated by increasing doses of romifidine. The effects of atropine sulphate (low or high doses) given 5 min after romifidine only appeared after 5 min. Both dosages counteracted the bradycardia and suppressed the heart blocks. No atropine-dependent side effects were observed in non-fasted horses. The degree of the romifidine induced sedation was not affected by the use of atropine sulphate given before or after romifidine.
Publication Date: 1990-01-01 PubMed ID: 1980962DOI: 10.1007/BF00367061Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research investigated the effects of Atropine Sulphate on bradycardia and heart blocks in horses that occur as a result of sedation using Romifidine, a newly developed sedative. It was found that Atropine Sulphate effectively counteracted these cardiovascular disturbances, without altering the effectiveness of the sedative or causing any notable side effects.
Methodology
- The exploratory study was conducted on nine warm-blood horses who were arbitrarily split into three groups.
- Each group was administered different dosages of Romifidine – 0.04, 0.08, and 0.12 mg/kg of body weight – through intravenous means, with a minimum seven-day gap between tests.
- In addition to Romifidine, the horses were also given a placebo (NaCl 0.9%) injected 5 minutes before and after the sedative, along with a small dose of Atropine Sulphate (0.005 mg/kg of body weight) also injected 5 minutes prior to administering Romifidine.
Findings
- It was observed that regardless of the dosage, Romifidine resulted in significant bradycardia, AV block, and some sinus blocks.
- The presence of the placebo did not influence the cardiac abnormalities caused by Romifidine.
- If administered prior to the sedative, Atropine Sulphate, even in low doses, effectively combated the bradycardia and brought about an average to increase in heart rhythm across all Romifidine dosages.
- A higher dose of Atropine Sulphate, injected 5 minutes before sedation, triggered tachycardia (average 70 beats/minute) at all Romifidine levels and completely stopped both the bradycardia and the heart blocks.
- Increasing the doses of Romifidine slightly reduced the chronotropic effects of Atropine Sulphate.
Conclusions
- Administering Atropine Sulphate, either in low or high doses, five minutes after Romifidine led to its effects being seen after about 5 minutes.
- Irrespective of the exact dosage, Atropine Sulphate effectively interrupted the bradycardia and nullified the heart blocks.
- There were no observed side-effects of Atropine in the horses that were not fasted.
- The sedative functioning of Romifidine was not impacted in any way because of the use of Atropine Sulphate, irrespective of whether it was given before or after the sedative.
Cite This Article
APA
Gasthuys F, Parmentier D, Goossens L, De Moor A.
(1990).
A preliminary study on the effects of atropine sulphate on bradycardia and heart blocks during romifidine sedation in the horse.
Vet Res Commun, 14(6), 489-502.
https://doi.org/10.1007/BF00367061 Publication
Researcher Affiliations
- Large Animal Surgical Clinic, Faculty of Veterinary Medicine, State University of Gent, Belgium.
MeSH Terms
- Adrenergic alpha-Agonists / adverse effects
- Animals
- Atropine / therapeutic use
- Bradycardia / chemically induced
- Bradycardia / prevention & control
- Bradycardia / veterinary
- Electrocardiography / veterinary
- Female
- Heart Block / chemically induced
- Heart Block / prevention & control
- Heart Block / veterinary
- Heart Rate / drug effects
- Horse Diseases / chemically induced
- Horses
- Hypnotics and Sedatives / adverse effects
- Imidazoles / adverse effects
- Random Allocation
References
This article includes 9 references
- Virtanen R. Pharmacology of detomidine and other alpha 2-adrenoceptor agonists in the brain.. Acta Vet Scand Suppl 1986;82:35-46.
- Aziz MA, Martin RJ. Alpha agonist and local anaesthetic properties of xylazine.. Zentralbl Veterinarmed A 1978 Apr;25(3):181-8.
- McCashin FB, Gabel AA. Evaluation of xylazine as a sedative and preanesthetic agent in horses.. Am J Vet Res 1975 Oct;36(10):1421-9.
- Short CE, Stauffer JL, Goldberg G, Vainio O. The use of atropine to control heart rate responses during detomidine sedation in horses.. Acta Vet Scand 1986;27(4):548-59.
- Kerr DD, Jones EW, Huggins K, Edwards WC. Sedative and other effects of xylazine given intravenously to horses.. Am J Vet Res 1972 Mar;33(3):525-32.
- Smetzer DL, Smith CR, Senta T. Second-degree atrioventricular block in the horse.. Am J Vet Res 1969 Jun;30(6):933-46.
- Clarke KW, Hall LW. "Xylazine"--a new sedative for horses and cattle.. Vet Rec 1969 Nov 8;85(19):512-7.
- Alitalo I, Vainio O, Kaartinen L, Raekallio M. Cardiac effects of atropine premedication in horses sedated with detomidine.. Acta Vet Scand Suppl 1986;82:131-6.
- Clarke KW, Taylor PM. Detomidine: a new sedative for horses.. Equine Vet J 1986 Sep;18(5):366-70.
Citations
This article has been cited 2 times.- Kerr CL, McDonell WN, Young SS. Cardiopulmonary effects of romifidine/ketamine or xylazine/ketamine when used for short duration anesthesia in the horse.. Can J Vet Res 2004 Oct;68(4):274-82.
- Marntell S, Nyman G. Effects of additional premedication on romifidine and ketamine anaesthesia in horses.. Acta Vet Scand 1996;37(3):315-25.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists